Dr. Mustafa Raoof

About Dr. Raoof

Dr. Mustafa Raoof specializes in mesothelioma care with a focus on advanced surgical treatment for peritoneal mesothelioma. At City of Hope, he plays a key role in one of the largest programs performing complex cytoreductive surgery combined with HIPEC. This approach helps remove cancer that has spread within the abdominal cavity, offering patients treatment options not widely available elsewhere.

Dr. Raoof combines expert surgical care with research on targeted therapies, aiming to improve outcomes for people with mesothelioma and other gastrointestinal cancers. He believes in personalized, compassionate care that integrates cutting-edge science. He says he chose City of Hope for its “culture of scientific discovery that accelerates adaptation of groundbreaking treatments to clinical cancer care.”

Close Button

Full Name

Diagnosis Please Select Mesothelioma Asbestosis Lung Cancer No Diagnosis Other Unknown

Zip Code

Email

Phone Number

Preferred Method of Contact Please Select Call Text

Message

Full Name

By submitting, you agree to our privacy policy and terms of service. Our Patient Advocates may contact you via phone, email and/or text.

Get Connected Now

Medical Education & Expertise

• City of Hope, Duarte, CA (Assistant Professor, Surgical Oncology and Cancer Genetics)
• City of Hope, Duarte, CA (Fellowship)
• University of Arizona (Residency)
• The University of Texas Health Science Center at Houston (Masters in Translational Sciences)
• MD Anderson Cancer Center, University of Texas (Fellowship)
• Yale-New Haven Hospital. Yale University (Internship)
• Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (Fellowship)
• Aga Khan University, Pakistan (M.D.)

Associations, Awards & Recognition

• American College of Surgeons, Faculty Research Fellowship, 2019-2021
• American Society of Clinical Oncology Conquer Cancer Foundation Merit Award, 2017 
• Board Certified in General Surgery, American Board of Surgery
• Board Certified in Complex General Surgical Oncology, American Board of Surgery
• Member American Association for Cancer Research
• Member American College of Surgeons
• Member Americas Hepato-Pancreato-Biliary Association
• Member American Society of Colorectal Surgeons
• Member Society for the Surgery of Alimentary Tract
• Member Society of Surgical Oncology
• NCCN Young Investigator Award, 2020-2022 
• Pancreatic Cancer Action Network Career Development Award, 2021-2023
• Young Innovator Award, City of Hope, 2018-2019 
• Young Investigator Award, Biology Informa-Yamamoto Society of Thermal Medicine, 2012 

Why Choose Dr. Raoof for Peritoneal Mesothelioma?

Dr. Raoof offers a unique blend of surgical expertise and laboratory research that targets difficult-to-treat gastrointestinal cancers like peritoneal mesothelioma. His leadership in one of the largest regional programs for cytoreductive surgery and heated chemotherapy provides patients with access to advanced treatment options not widely available.

Patients benefit from Dr. Raoof’s commitment to personalized care, combining cutting-edge surgical methods with ongoing research designed to develop new therapies. His focus on integrating science with compassionate care makes him a trusted partner in complex mesothelioma treatment.

Publications of Dr. Mustafa Raoof

• Raoof, M. et al. (2013, February). Remotely triggered cisplatin release from carbon nanocapsules by radiofrequency fields. Retrieved from https://pubmed.ncbi.nlm.nih.gov/23228421/
• Raoof, M. et al. (2012, November 15). Citrate-capped gold nanoparticle electrophoretic heat production in response to a time-varying radiofrequency electric-field. Retrieved from https://pubmed.ncbi.nlm.nih.gov/23795228/
• Raoof, M. et al. (2012, April). Internalization of C60 fullerenes into cancer cells with accumulation in the nucleus via the nuclear pore complex. Retrieved from https://pubmed.ncbi.nlm.nih.gov/22245558/
• Raoof, M. et al. (2012, February 17). Stability of antibody-conjugated gold nanoparticles in the endo-lysosomal nanoenvironment: Implications for non-invasive radiofrequency-based cancer therapy. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC3392470/